Answers are grounded in this paper and cite their sources.
Chemical probes enable selective modulation of protein function in live cells, making them valuable tools for studying the roles of proteins in normal and disease physiology. Although initiatives such as the chemical probe development programme at the Structural Genomics Consortium have expanded access to chemial probes for selected target classes, the general availability across the druggable proteome remains limited, particularly for compounds developed within the pharmaceutical industry. The donated chemical probe (DCP) programme addresses this gap through an open-science model that combines unrestricted access to donated probes with comprehensive characterisation data and independent expert review. Since its launch in 2017, the programme has become an important resource for basic as well as translational research. More than 20 organisations have contributed to the initiative, resulting in a collection of about 140 chemical probes together with matched control compounds and previously inaccessible characterisation data that had often remained confined to patents or internal reports. The present review summarises recent developments of the DCP programme and highlights representative examples including case studies such as the BUB1 chemical probe BAY 1816032.
No takes yet. Share an insight, caveat, or question.
Haeberle et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: